DUBLIN, Sept. 23, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Biopharmaceutical and Vaccine Production Markets" report to their offering.
Though biotechnology has created many new therapies and vaccines - including products to treat cancer, diabetes, HIV/AIDS and autoimmune disorders - there are still huge challenges during the final stages of clinical drug testing for new biopharmaceuticals, as manufacturers decide when and how to risk production capital to upscale while anticipating FDA or EMA approval. During the past five years, estimates for biopharmaceuticals have varied widely as analysts and producers have juggled the promise of new drugs with the technological and financial risks of manufacturing them efficiently.
Biopharmaceutical and Vaccine Production Markets examines the total biopharmaceutical manufacturing market, including in its estimates all costs related to biopharmaceutical and vaccine production. It includes the following useful information for business planning:
- Market Forecasts and Estimates of Biopharmaceutical Manufacturing Costs
- Vaccine Production Estimates
- Trend Discussion
- Production Methods
- The Competitive Environment, including Contract Manufacturing and Outsourcing
- Regulation of the Market
- Company Profiles
The report contains production segmentations for the mammalian cell, microbial cell, monoclonal antibody, other recombinant protein, vaccine, and insulin manufacturing markets, with forecasts to 2018. The current competitive environment is noted, listing selected biopharmaceutical contract manufacturers, selected top-selling biopharmaceuticals, selected Asian biomanufacturing contract manufacturing organizations (CMOs), the top 10 biopharma companies based on 2012 biopharma revenues, and the top manufacturers by global biopharmaceutical manufacturing capacity.
This report profiles major contract manufacturers:
- Lonza AG
- Boehringer Ingelheim GmbH
- FUJIFILM Diosynth Biotechnologies
- Sandoz
- Royal DSM
- Rentschler Biotechnologie
- Celonic
- BIOMEVA GmbH
- ProBioGen AG
- Baxter BioPharma Solutions/Baxter Bioscience
Major biologics firms are also profiled:
- Amgen
- Genentech/Roche
- AbbVie Inc. (Abbott)
- Biogen Idec
- Regeneron Pharmaceuticals
- Alexion Pharmaceuticals
- Crucell /Johnson & Johnson
- GlaxoSmithKline
- Merck & Co. Inc
- Novartis
- Pfizer
- Sanofi Pasteur
Other contract manufacturers are profiled as well:
- AAIPharma
- A-Bio Pharma Pte Ltd.
- ABL, Inc.
- Affinity Life Sciences, Inc.
- Ajinomoto Aminoscience, LLC
- Alliance Medical Products, Inc.
- Alpha Biologics
- Biotecnol
- Boston Mountain Biotech
- Glycobia
- Sutro Biopharma
Key Topics Covered:
ONE: Executive Summary
TWO: Commercial Production
THREE: Forecasts
FOUR: Regulation
FIVE: Competitive Environment
SIX: Patents
SEVEN: Geography
EIGHT: Profiles
For more information visit http://www.researchandmarkets.com/research/5tjn3j/biopharmaceutical
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article